Excessive activation of IFN pathways can drive endothelial dysfunction by inducing the expression of adhesion molecules and chemokines such as vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1) [209, 210]. The gene discussed is CCL2; the disease is endothelial dysfunction.